Latest Share Options News

Osmond Resources has significantly expanded its Orion EU Critical Minerals Project by 160%, with promising assay results and a planned drilling program to confirm mineral continuity. The company is positioning itself to benefit from strong EU demand for rare earths, titanium, and silicon metals.

BPM Minerals has agreed to sell its Claw Gold Project to Capricorn Metals for $1.5 million upfront, with potential milestone payments doubling the deal value. This transaction strengthens BPM’s cash position to fund exploration at its promising Forelands Gold Project near Kalgoorlie.

Osmond Resources has significantly expanded its Orion EU Critical Minerals Project in Southern Spain by 160%, adding three new permits and preparing for a targeted drilling campaign to confirm mineral continuity.

Dateline Resources’ Managing Director Stephen Baghdadi has exercised over 53 million options, injecting more than $1 million into the company and increasing his shareholding to nearly 13%. This capital boost aims to accelerate exploration and development at the promising Colosseum Gold and Rare Earth Elements Project in California.

S2 Resources Ltd invites eligible shareholders to participate in a Share Purchase Plan offering new shares at $0.072 each, accompanied by free options exercisable until mid-2027. The plan aims to raise up to $0.5 million, subject to scale back if oversubscribed.

TruScreen Group Limited has launched a NZ$1.22 million Share Purchase Plan offering discounted shares to eligible investors, aiming to fuel growth in key international markets and public health initiatives.

Macarthur Minerals Limited has launched a pro-rata entitlement offer to raise nearly $2 million, issuing new shares with free attaching options, fully underwritten by Gold Valley Yilgarn Pty Ltd. The capital raise aims to advance exploration and development at its Giles Lake Iron Project and support corporate operations.

Trinex Minerals Limited has announced a significant 127:1 security consolidation affecting its ordinary shares, options, and performance rights, pending shareholder approval and set to reshape its capital structure by mid-July.

Neuren Pharmaceuticals has approved a significant long-term equity incentive plan tied to critical clinical and regulatory milestones for its drug candidate NNZ-2591, reinforcing management’s commitment to shareholder value.

Estrella Resources has entered a landmark Master Agreement with Indonesian firm PT Raka Energi Mandiri, granting exclusive rights to market and purchase limestone from Timor-Leste, targeting sales of up to 500 million tonnes over five years.

BluGlass Limited has launched a $6 million Share Purchase Plan (SPP) offering new shares with attaching options to eligible shareholders, aiming to fund the scale-up of its visible laser production and support ongoing product development.

Oncosil Medical Ltd has announced a significant 400-for-1 security consolidation affecting shares, options, and performance rights, with shareholder approval scheduled for late May 2025.